272 related articles for article (PubMed ID: 28742500)
1. Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications.
Tzortzis V; Samarinas M; Zachos I; Oeconomou A; Pisters LL; Bargiota A
Hormones (Athens); 2017 Apr; 16(2):115-123. PubMed ID: 28742500
[TBL] [Abstract][Full Text] [Related]
2. Metabolic complications of androgen deprivation therapy for prostate cancer.
Saylor PJ; Smith MR
J Urol; 2009 May; 181(5):1998-2006; discussion 2007-8. PubMed ID: 19286225
[TBL] [Abstract][Full Text] [Related]
3. Metabolic complications of androgen deprivation therapy for prostate cancer.
Saylor PJ; Smith MR
J Urol; 2013 Jan; 189(1 Suppl):S34-42; discussion S43-4. PubMed ID: 23234628
[TBL] [Abstract][Full Text] [Related]
4. Androgen deprivation therapy: evidence-based management of side effects.
Ahmadi H; Daneshmand S
BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy.
Saylor PJ; Keating NL; Smith MR
J Gen Intern Med; 2009 Nov; 24 Suppl 2(Suppl 2):S389-94. PubMed ID: 19838837
[TBL] [Abstract][Full Text] [Related]
6. Metabolic changes in patients with prostate cancer during androgen deprivation therapy.
Mitsuzuka K; Arai Y
Int J Urol; 2018 Jan; 25(1):45-53. PubMed ID: 29052905
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: a review.
Collier A; Ghosh S; McGlynn B; Hollins G
Am J Clin Oncol; 2012 Oct; 35(5):504-9. PubMed ID: 21297430
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer.
Gupta D; Lee Chuy K; Yang JC; Bates M; Lombardo M; Steingart RM
J Oncol Pract; 2018 Oct; 14(10):580-587. PubMed ID: 30312560
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications.
Collins L; Basaria S
Asian J Androl; 2012 Mar; 14(2):222-5. PubMed ID: 22343494
[TBL] [Abstract][Full Text] [Related]
10. Uncovering the metabolic complications of androgen deprivation therapy in patients with prostate cancer--where do we take it next?
Pinthus JH
J Urol; 2015 Jun; 193(6):1882-3. PubMed ID: 25794833
[No Abstract] [Full Text] [Related]
11. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis.
Shahani S; Braga-Basaria M; Basaria S
J Clin Endocrinol Metab; 2008 Jun; 93(6):2042-9. PubMed ID: 18349064
[TBL] [Abstract][Full Text] [Related]
12. Complications of androgen deprivation therapy in prostate cancer.
Schwandt A; Garcia JA
Curr Opin Urol; 2009 May; 19(3):322-6. PubMed ID: 19318949
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer.
Kintzel PE; Chase SL; Schultz LM; O'Rourke TJ
Pharmacotherapy; 2008 Dec; 28(12):1511-22. PubMed ID: 19025432
[TBL] [Abstract][Full Text] [Related]
14. Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancer.
Saylor PJ; Smith MR
J Natl Compr Canc Netw; 2010 Feb; 8(2):211-23. PubMed ID: 20141678
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk with androgen deprivation therapy for prostate cancer: potential mechanisms.
Tivesten Å; Pinthus JH; Clarke N; Duivenvoorden W; Nilsson J
Urol Oncol; 2015 Nov; 33(11):464-75. PubMed ID: 26141678
[TBL] [Abstract][Full Text] [Related]
16. Androgen deprivation therapy for prostate cancer.
Sharifi N; Gulley JL; Dahut WL
JAMA; 2005 Jul; 294(2):238-44. PubMed ID: 16014598
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risks of androgen deprivation therapy.
Ribeiro AF; Camara C; Segre CA; Srougi M; Serrano CV
Arq Bras Cardiol; 2010 Sep; 95(3):412-5. PubMed ID: 20944900
[TBL] [Abstract][Full Text] [Related]
18. Management of the side effects of androgen deprivation therapy in men with prostate cancer.
Flaig TW; Glodé LM
Expert Opin Pharmacother; 2008 Nov; 9(16):2829-41. PubMed ID: 18937615
[TBL] [Abstract][Full Text] [Related]
19. Management of complications of androgen deprivation therapy in the older man.
Mohile SG; Mustian K; Bylow K; Hall W; Dale W
Crit Rev Oncol Hematol; 2009 Jun; 70(3):235-55. PubMed ID: 18952456
[TBL] [Abstract][Full Text] [Related]
20. Complications of androgen-deprivation therapy in prostate cancer: the other side of the coin.
Hoffmann P; Schulman C
BJU Int; 2009 Apr; 103(8):1020-3. PubMed ID: 19348058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
